Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/1998
06/17/1998EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10
06/17/1998EP0745124B1 Mammalian cell cycle protein
06/17/1998EP0683662B1 Waterproof cosmetic or dermatological photoprotective preparations
06/17/1998CN1185107A Pharmaceutical composition contg. proton pump inhititors
06/17/1998CN1185106A Use of carbazole compounds for treating congestive heart failure
06/16/1998US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof
06/16/1998US5767160 Method and formulation of stimulating nitric oxide synthesis
06/16/1998US5767148 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carbonylbenzoic acid ethylene acetal and 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carboxylamidobenzoic acid having retinoid activityp; leukemia
06/16/1998US5767135 Antiviral agent
06/16/1998US5767130 Use of kainic acid antagonists to prevent toxic side effects of NMDA antagonists
06/16/1998US5767124 Polymorphic forms of a growth hormone secretagogue
06/16/1998US5767123 Total parenteral nutrition solution containing water-soluble vitamin B
06/16/1998US5767119 Method of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agent
06/16/1998US5767117 Method for treating vascular headaches
06/16/1998US5767106 Treatment of disease and conditions associated with macrophage infiltration
06/16/1998US5767105 Ocular solution
06/16/1998US5767098 Anti-acne method and composition
06/16/1998US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
06/16/1998US5766948 Culturing neuroblast cells in vessel in serum-free basal medium supplemented with basic fibroblast growth factor, wherein surface of vessel allows attachment of cells
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766633 Modified amino acid carrier, bioactive peptides
06/16/1998US5766619 Pharmaceutical dosage form for ocular administration and preparation process
06/16/1998US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders
06/16/1998US5766591 Methods and compositions useful for inhibition of angiogenesis
06/16/1998US5766580 Controlled release of miotic and mydriatic drugs in the anterior chamber
06/16/1998US5766571 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids
06/16/1998US5766520 Preservation by foam formation
06/16/1998CA2065965C Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
06/11/1998WO1998024916A1 Novel calpaines, production and use thereof
06/11/1998WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods
06/11/1998WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
06/11/1998WO1998024478A2 Tumour therapy
06/11/1998WO1998024477A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
06/11/1998WO1998024476A1 Method to prevent transplant rejection
06/11/1998WO1998024474A1 Inhibition of invasive remodelling
06/11/1998WO1998024465A1 Wound healing and treatment of fibrosis
06/11/1998WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998WO1998024447A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998WO1998024446A1 Use of nk-1 receptor antagonists for treating movement disorders
06/11/1998WO1998024445A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders
06/11/1998WO1998024444A1 Use of nk-1 receptor antagonists for treating substance use disorders
06/11/1998WO1998024443A1 Use of nk-1 receptor antagonists for treating bipolar disorders
06/11/1998WO1998024442A1 Use of nk-1 receptor antagonists for treating sexual dysfunction
06/11/1998WO1998024441A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
06/11/1998WO1998024440A1 Use of nk-1 receptor antagonists for treating stress disorders
06/11/1998WO1998024439A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders
06/11/1998WO1998024438A1 Use of nk-1 receptor antagonists for treating major depressive disorders
06/11/1998WO1998024434A1 Novel therapeutic application of a thienycyclohexylamine derivative
06/11/1998WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998WO1998024397A2 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
06/11/1998WO1998012910A3 Novel CREBa isoform
06/11/1998CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274304A1 Novel calpaines, production and use thereof
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998CA2274002A1 Wound healing and treatment of fibrosis
06/11/1998CA2273856A1 Use of nk-1 receptor antagonists for treating bipolar disorders
06/11/1998CA2273853A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998CA2273810A1 Use of nk-1 receptor antagonists for treating major depressive disorders
06/11/1998CA2273809A1 Use of nk-1 receptor antagonists for treating movement disorders
06/11/1998CA2273807A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders
06/11/1998CA2273806A1 Use of nk-1 receptor antagonists for treating substance use disorders
06/11/1998CA2273800A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
06/11/1998CA2273786A1 Use of nk-1 receptor antagonists for treating stress disorders
06/11/1998CA2273785A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders
06/11/1998CA2273351A1 Use of nk-1 receptor antagonists for treating sexual dysfunction
06/11/1998CA2273218A1 Tumour therapy
06/11/1998CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846265A1 Methods for g protein coupled receptor activity screening
06/10/1998EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection
06/10/1998EP0845989A2 Pain-alleviating drug composition and method for alleviating pain
06/10/1998EP0831817A4 Antigen-processing cell-targeted conjugates
06/10/1998EP0710105A4 Synergistic anthelmintic compositions
06/10/1998EP0675719B1 Novel combination of benzoquinazoline antifolates and protecting agents
06/10/1998DE19652418A1 Verwendung von Nucleosiden, Nucleobasen und deren Derivaten zum Herabsetzen toxischer Nebenwirkungen von Cytostatika Use of nucleosides, nucleobases and their derivatives for reducing toxic side effects of cytostatics
06/10/1998DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation
06/10/1998DE19650778A1 Dopamine receptor antagonists
06/10/1998CN1184420A Production scale method of forming microparticles
06/09/1998US5763496 Selected from catechols and ortho-methoxyphenols
06/09/1998US5763459 5-ht receptor antagonist
06/09/1998US5763452 Nonsteroid antiarthritic antiinflammatory agents
06/09/1998US5763429 Method of treating prostatic diseases using active vitamin D analogues
06/09/1998US5763425 Gastrointestinal toxicity side effect inhibition
06/09/1998US5763399 Revitalizing tissues with growth factor
1 ... 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 ... 1151